{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:03:17Z","timestamp":1790643797198,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,7,18]],"date-time":"2007-07-18T00:00:00Z","timestamp":1184716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,9,28]]},"DOI":"10.1007\/s10067-007-0694-y","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T12:08:03Z","timestamp":1184674083000},"page":"1913-1915","source":"Crossref","is-referenced-by-count":24,"title":["Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases"],"prefix":"10.1007","volume":"26","author":[{"given":"Fatih","family":"Tufan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevil","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Erer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Inanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Ocal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Konice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Aral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,18]]},"reference":[{"key":"694_CR1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00296-003-0422-0","volume":"25","author":"S Kamali","year":"2005","unstructured":"Kamali S, Cefle A, Sayarlioglu M, Gul A, Inanc M, Ocal L et al (2005) Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases. Rheumatol Int 25:211\u2013214","journal-title":"Rheumatol Int"},{"key":"694_CR2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(85)90400-3","volume":"2","author":"P Imbach","year":"1985","unstructured":"Imbach P, Wagner H, Berchtold W, Gaedicke G, Hirt A, Joller P et al (1985) Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 2:464\u2013468","journal-title":"Lancet"},{"key":"694_CR3","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","volume":"324","author":"JW Newburger","year":"1991","unstructured":"Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treament of acute Kawasaki syndrome. N Engl J Med 324:1633\u20131639","journal-title":"N Engl J Med"},{"key":"694_CR4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"MD Kazatchkine","year":"2001","unstructured":"Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747\u2013755","journal-title":"N Engl J Med"},{"key":"694_CR5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","volume":"291","author":"A Samuelsson","year":"2001","unstructured":"Samuelsson A, Towers TL, Ravetch JV (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291:484\u2013486","journal-title":"Science"},{"key":"694_CR6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/CRIAI:29:3:173","volume":"29","author":"H Orbach","year":"2005","unstructured":"Orbach H, Katz U, Sherer Y, Schoenfeld Y (2005) Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol 29:173","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6 Suppl 2","key":"694_CR7","first-page":"35","volume":"78","author":"C Schiavotto","year":"1993","unstructured":"Schiavotto C, Ruggeri M, Rodeghiero F (1993) Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica 78(6 Suppl 2):35\u201340","journal-title":"Haematologica"},{"key":"694_CR8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"694_CR9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum 33:1101\u20131107","journal-title":"Arthritis Rheum"},{"key":"694_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-409-95191-2.50005-7","volume-title":"Polymyositis and dermatomyositis","author":"MC Dalakas","year":"1988","unstructured":"Dalakas MC (1988) A classification of polymyositis and dermatomyositis. In: Dalakas MC (ed) Polymyositis and dermatomyositis. Butterworth, Boston, pp 1\u201316"},{"key":"694_CR11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309\u20131311","journal-title":"Arthritis Rheum"},{"issue":"4","key":"694_CR12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","volume":"44","author":"JH Stone","year":"2001","unstructured":"Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB et al (2001) A disease-specific activity index for Wegener\u2019s granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44(4):912\u2013920","journal-title":"Arthritis Rheum"},{"issue":"10","key":"694_CR13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1191\/0961203303lu2168rr","volume":"14","author":"U Katz","year":"2005","unstructured":"Katz U, Shoenfeld Y (2005) Review: intravenous immunoglobulin therapy and thromboembolic complications. Lupus 14(10):802\u2013808","journal-title":"Lupus"},{"issue":"8","key":"694_CR14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-142-8-200505030-00011","volume":"142","author":"PA Merkel","year":"2005","unstructured":"Merkel PA, Lo GH, Holbrook JT, Tibbs AK, Allen NB, Davis JC et al (2005) Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener\u2019s Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 142(8):620\u2013626","journal-title":"Ann Intern Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0694-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0694-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0694-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:08Z","timestamp":1559119868000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0694-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,18]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,9,28]]}},"alternative-id":["694"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0694-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,18]]}}}